Status:
COMPLETED
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
Lead Sponsor:
Kaiser Franz Josef Hospital
Conditions:
Platelet Inhibition
Coronary Stent Implantation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the efficacy and safety of a routine individualized antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet reactivity wi...
Detailed Description
Depending on the clinical presentation patients are treated according to standard operating procedures in our department. The earliest, 12 hours after an initial clopidogrel-loading dose (600mg)"on-tr...
Eligibility Criteria
Inclusion
- all consecutive PCI patients with stent implantation of our institution
Exclusion
- pregnancy
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
1008 Patients enrolled
Trial Details
Trial ID
NCT01515345
Start Date
July 1 2011
End Date
January 1 2013
Last Update
April 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Franz Josef Hospital
Vienna, Vienna, Austria, 1100